Physician profile
Edward Hunter Redd
NPI 1578597647
$377.34
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.63 · 2020: $203 · 2021: $109 · 2022: $24.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $202.80 | 2020 | |
| Abbvie INC. | $42.61 | 2021 | |
| Vanda Pharmaceuticals INC. | $27.65 | 2021 | |
| Allergan, INC. | $27.46 | 2019 | |
| Indivior INC. | $24.31 | 2022 | |
| Alkermes, INC. | $20.62 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.72 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Redd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.